K807-1107 Screening compound: 1'-[4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-2-nitrophenyl]-1,4'-bipiperidine-4'-carboxamide

K807-1107 Screening compound: 1'-[4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-2-nitrophenyl]-1,4'-bipiperidine-4'-carboxamide
K807-1107 Screening compound: 1'-[4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-2-nitrophenyl]-1,4'-bipiperidine-4'-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K807-1107
1'-[4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-2-nitrophenyl]-1,4'-bipiperidine-4'-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K807-1107

Molecular Formula

C26H31N5O5 (C26 H31 N5 O5)

Compound Name

1'-[4-(1,3-dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-methanoisoindol-2-yl)-2-nitrophenyl]-1,4'-bipiperidine-4'-carboxamide

IUPAC name

1'-(4-{35-dioxo-4-azatricyclo[5.2.1.0^{26}]dec-8-en-4-yl}-2-nitrophenyl)-[14'-bipiperidine]-4'-carboxamide

SMILES

NC(C(CC1)(CCN1c(ccc(N(C(C1C2C3C=CC1C3)=O)C2=O)c1)c1[N+]([O-])=O)N1CCCCC1)=O

InChI

InChI=1S/C26H31N5O5/c27-25(34)26(29-10-2-1-3-11-29)8-12-28(13-9-26)19-7-6-18(15-20(19)31(35)36)30-23(32)21-16-4-5-17(14-16)22(21)24(30)33/h4-7,15-17,21-22H,1-3,8-14H2,(H2,27,34)

InChI Key

IMKMNSNJOBJBOY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05028238

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

493.56

Hydrogen Bond Acceptors Count

11.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.943

Distribution Coefficient, logD

1.631

Water Solubility, LogSw

-2.73

Polar Surface Area

103.092

Acid Dissociation Constant (pKa)

14.52

Base Dissociation Constant (pKb)

7.42

Number of Chiral Centers

4.00

Percent sp3 carbon bonding

57.70

K807-1107 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Hemic and lymphatic
  • Cardiovascular
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Proteases
  • Phosphatases

References: we are preparing a list of scientific research reports with K807-1107 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K807-1107?
Check Price and Availability of K807-1107, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K807-1107 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K807-1107
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K807-1107
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K807-1107 available by request